The parenteral nutrition market reached a value of nearly $5,823.4 million in 2021, having grown at a compound annual growth rate (CAGR) of 4.5% since 2016. The market is expected to grow from $5,823.4 million in 2021 to $7,694.2 million in 2026 at a rate of 5.7%. The market is then expected to grow at a CAGR of 6.3% from 2026 and reach $10,423.8 million in 2031.
Growth in the historic period resulted from growing rate of premature births, rising functional gastro-intestinal disorders, government investments to reduce the burden of malnutrition, rising prevalence of chronic diseases, and increased healthcare expenditure. The market was restrained by low healthcare access and risks and possible complications associated with parenteral nutrition.
Going forward, increasing geriatric population, increasing prevalence of malnutrition, benefits associated with parenteral nutrition, and increasing birth rate. Factors that could hinder the growth of the parenteral nutrition market in the future include stringent government regulations.
The parenteral nutrition market is segmented by composition into amino acids, carbohydrates, lipid emulsion, trace elements, vitamins and minerals, and other compositions. The amino acids market was the largest segment of the parenteral nutrition market segmented by composition, accounting for 32.9% of the total in 2021. Going forward, the lipid emulsion segment is expected to be the fastest growing segment in the parenteral nutrition market segmented by composition, at a CAGR of 6.0% during 2021-2026.
The parenteral nutrition market is segmented by consumer type into children and new-born, adults, and geriatrics. The children and new-born market was the largest segment of the parenteral nutrition market segmented by consumer type, accounting for 42.3% of the total in 2021. Going forward, the children and new-born segment is expected to be the fastest growing segment in the parenteral nutrition market segmented by consumer type, at a CAGR of 6.0% during 2021-2026.
The parenteral nutrition market is segmented by end-user into hospitals, clinics, homecare, and other end-users. The hospitals market was the largest segment of the parenteral nutrition market segmented by end-user, accounting for 64.8% of the total in 2021. Going forward, the clinics segment is expected to be the fastest growing segment in the parenteral nutrition market segmented by end-user, at a CAGR of 6.2% during 2021-2026.
North America was the largest region in the parenteral nutrition market, accounting for 33.7% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the parenteral nutrition market will be Asia Pacific, and, North America where growth will be at CAGRs of 6.2% and 6.0% respectively. These will be followed by Western Europe, and, South America where the markets are expected to grow at CAGRs of 5.7% and 5.1% respectively.
The global parenteral nutrition market is moderately fragmented with large number of players operating in the market. The top ten competitors in the market made up to 45.50% of the total market in 2021. Baxter International, Inc was the largest competitor with 16.55% share of the market, followed by Fresenius SE & Co. KGaA with 9.63%, Otsuka Pharmaceutical Factory, Inc. with 7.60%, B. Braun Melsungen AG with 5.23%, Sichuan Kelun Pharmaceutical Co., Ltd with 2.77%, American Regent Inc. with 1.66%, JW Pharmaceutical with 1.04%, Grifols S.A.with 0.44%, Amanta Healthcare with 0.26%, and ICU Medical, Inc. with 0.32%.
The top opportunities in the parenteral nutrition market segmented by composition will arise in the amino acids market segment, which will gain $605.4 million of global annual sales by 2026. The top opportunities in the parenteral nutrition market segmented by consumer type will arise in the children and new-born market segment, which will gain $833.6 million of global annual sales by 2026. The top opportunities in the parenteral nutrition market segmented by end-user will arise in the hospitals market segment, which will gain $1190.3 million of global annual sales by 2026. The top opportunities in the parenteral nutrition market size will gain the most in USA at $594.5 million.
Market-trend-based strategies for the parenteral nutrition include companies should focus on the launch of glass packaging system, focus on innovating new products such as olive oil-based parenteral nutrition, introducing innovative products with innovations such as four-oil lipid injectable emulsion, introducing parenteral nutrition products packages with barcode assistance, and undergoing partnerships to develop new products.
Player-adopted strategies in the parenteral nutrition market includes helping clinicians in meeting their patients’ nutritional goals through the launch of new products, expanding its parenteral nutrition portfolio through new product launches, emerging as the best partner for healthcare professionals and patients in the field of clinical nutrition through new product developments, and enhancing its business operations through the launches.
To take advantage of the opportunities, the publisher recommends the parenteral nutrition companies to focus on use of glass packaging for parenteral nutrition products, focus on olive oil-based parenteral nutrition, launch innovative products, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, leverage online portals to maximize reach and revenues, continue to target fast-growing end-users, target fast-growing consumer types.
This report describes and explains the parenteral nutrition market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from growing rate of premature births, rising functional gastro-intestinal disorders, government investments to reduce the burden of malnutrition, rising prevalence of chronic diseases, and increased healthcare expenditure. The market was restrained by low healthcare access and risks and possible complications associated with parenteral nutrition.
Going forward, increasing geriatric population, increasing prevalence of malnutrition, benefits associated with parenteral nutrition, and increasing birth rate. Factors that could hinder the growth of the parenteral nutrition market in the future include stringent government regulations.
The parenteral nutrition market is segmented by composition into amino acids, carbohydrates, lipid emulsion, trace elements, vitamins and minerals, and other compositions. The amino acids market was the largest segment of the parenteral nutrition market segmented by composition, accounting for 32.9% of the total in 2021. Going forward, the lipid emulsion segment is expected to be the fastest growing segment in the parenteral nutrition market segmented by composition, at a CAGR of 6.0% during 2021-2026.
The parenteral nutrition market is segmented by consumer type into children and new-born, adults, and geriatrics. The children and new-born market was the largest segment of the parenteral nutrition market segmented by consumer type, accounting for 42.3% of the total in 2021. Going forward, the children and new-born segment is expected to be the fastest growing segment in the parenteral nutrition market segmented by consumer type, at a CAGR of 6.0% during 2021-2026.
The parenteral nutrition market is segmented by end-user into hospitals, clinics, homecare, and other end-users. The hospitals market was the largest segment of the parenteral nutrition market segmented by end-user, accounting for 64.8% of the total in 2021. Going forward, the clinics segment is expected to be the fastest growing segment in the parenteral nutrition market segmented by end-user, at a CAGR of 6.2% during 2021-2026.
North America was the largest region in the parenteral nutrition market, accounting for 33.7% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the parenteral nutrition market will be Asia Pacific, and, North America where growth will be at CAGRs of 6.2% and 6.0% respectively. These will be followed by Western Europe, and, South America where the markets are expected to grow at CAGRs of 5.7% and 5.1% respectively.
The global parenteral nutrition market is moderately fragmented with large number of players operating in the market. The top ten competitors in the market made up to 45.50% of the total market in 2021. Baxter International, Inc was the largest competitor with 16.55% share of the market, followed by Fresenius SE & Co. KGaA with 9.63%, Otsuka Pharmaceutical Factory, Inc. with 7.60%, B. Braun Melsungen AG with 5.23%, Sichuan Kelun Pharmaceutical Co., Ltd with 2.77%, American Regent Inc. with 1.66%, JW Pharmaceutical with 1.04%, Grifols S.A.with 0.44%, Amanta Healthcare with 0.26%, and ICU Medical, Inc. with 0.32%.
The top opportunities in the parenteral nutrition market segmented by composition will arise in the amino acids market segment, which will gain $605.4 million of global annual sales by 2026. The top opportunities in the parenteral nutrition market segmented by consumer type will arise in the children and new-born market segment, which will gain $833.6 million of global annual sales by 2026. The top opportunities in the parenteral nutrition market segmented by end-user will arise in the hospitals market segment, which will gain $1190.3 million of global annual sales by 2026. The top opportunities in the parenteral nutrition market size will gain the most in USA at $594.5 million.
Market-trend-based strategies for the parenteral nutrition include companies should focus on the launch of glass packaging system, focus on innovating new products such as olive oil-based parenteral nutrition, introducing innovative products with innovations such as four-oil lipid injectable emulsion, introducing parenteral nutrition products packages with barcode assistance, and undergoing partnerships to develop new products.
Player-adopted strategies in the parenteral nutrition market includes helping clinicians in meeting their patients’ nutritional goals through the launch of new products, expanding its parenteral nutrition portfolio through new product launches, emerging as the best partner for healthcare professionals and patients in the field of clinical nutrition through new product developments, and enhancing its business operations through the launches.
To take advantage of the opportunities, the publisher recommends the parenteral nutrition companies to focus on use of glass packaging for parenteral nutrition products, focus on olive oil-based parenteral nutrition, launch innovative products, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, leverage online portals to maximize reach and revenues, continue to target fast-growing end-users, target fast-growing consumer types.
This report describes and explains the parenteral nutrition market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Market Segmentation By Composition
6.3.1. Amino Acids
6.3.2. Carbohydrates
6.3.3. Lipid Emulsion
6.3.4. Trace Elements
6.3.5. Vitamins And Minerals
6.3.6. Other Compositions
6.4. Market Segmentation By Consumer Type
6.4.1. Children And Newborns
6.4.2. Adults
6.4.3. Geriatrics
6.5. Market Segmentation By End-User
6.5.1. Hospitals
6.5.2. Clinics
6.5.3. Homecare
6.5.4. Other End-Users
7. Major Market Trends
7.1. Glass Packaging In Parental Nutrition Products
7.2. Olive Oil-based Parental Nutrition
7.3. Product Innovations
7.4. Introduction Of Barcode Assistance
7.5. Strategic Partnerships
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 2026
8.4. Market Restraints 2021 - 2026
9. Global Market Segmentation
9.1. Global Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Parenteral Nutrition Market, Segmentation By Consumer Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Parenteral Nutrition Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Parenteral Nutrition Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia Pacific Parenteral Nutrition Market: Country Analysis
11.8. China Market
11.9. Summary
11.10. Market Overview
11.10.1. Region Information
11.10.2. Market Information
11.10.3. Background Information
11.10.4. Government Initiatives
11.10.5. Regulations
11.10.6. Regulatory Bodies
11.10.7. Major Associations
11.10.8. Taxes Levied
11.10.9. Corporate Tax Structure
11.10.10. Investments
11.10.11. Major Companies
11.11. China Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.12. China Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.13. China Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.14. China Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15. India Market
11.16. India Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.17. India Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.18. India Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.19. India Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.20. Japan Market
11.21. Japan Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.22. Japan Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.23. Japan Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.24. Japan Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.25. Australia Market
11.26. Australia Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.27. Australia Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.28. Australia Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.30. Indonesia Market
11.31. Indonesia Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.32. Indonesia Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.33. Indonesia Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.34. Indonesia Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.35. South Korea Market
11.36. South Korea Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.37. South Korea Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.38. South Korea Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.39. South Korea Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Parenteral Nutrition Market: Country Analysis
12.8. UK Market
12.9. UK Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.10. UK Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.11. UK Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.12. UK Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. Germany Market
12.14. Germany Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.15. Germany Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.16. Germany Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.17. Germany Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.18. France Market
12.19. France Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.20. France Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.21. France Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.22. France Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Parenteral Nutrition Market: Country Analysis
13.8. Russia Market
13.9. Russia Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.10. Russia Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.11. Russia Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.12. Russia Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Parenteral Nutrition Market: Country Analysis
14.8. USA Market
14.9. Summary
14.10. Market Overview
14.10.1. Region Information
14.10.2. Market Information
14.10.3. Background Information
14.10.4. Government Initiatives
14.10.5. Regulations
14.10.6. Regulatory Bodies
14.10.7. Major Associations
14.10.8. Taxes Levied
14.10.9. Corporate Tax Structure
14.10.10. Investments
14.10.11. Major Companies
14.11. USA Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.12. USA Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.13. USA Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.14. USA Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Parenteral Nutrition Market: Country Analysis
15.8. Brazil Market
15.9. Brazil Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.10. Brazil Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.11. Brazil Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.12. Brazil Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Parenteral Nutrition Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa Parenteral Nutrition Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa Parenteral Nutrition Market, Segmentation By Composition, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Parenteral Nutrition Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Baxter International, Inc
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Fresenius SE & Co. KGaA
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Otsuka Pharmaceutical Factory, Inc
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. B. Braun Melsungen AG
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Financial Overview
18.6. Sichuan Kelun Pharmaceutical Co., Ltd
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers and Acquisitions
19.1. CSL Acquired Vifor Pharma
19.2. Fresenius Kabi Acquired mAbxience Holding S.L
19.3. Baxter International Acquired Hillrom
19.4. Wellspring Capital Management Acquired Pentec Health Inc.
19.5. PAI Partners Acquired SGD Pharma
20. Market Opportunities And Strategies
20.1. Global Parenteral Nutrition Market In 2026 - Countries Offering Most New Opportunities
20.2. Global Parenteral Nutrition Market In 2026 - Segments Offering Most New Opportunities
20.3. Global Parenteral Nutrition Market In 2026 - Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Parenteral Nutrition Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. About the Publisher
22.5. Copyright and Disclaimer
Executive Summary
Parenteral Nutrition Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global parenteral nutrition market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider parenteral nutrition market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the parenteral nutrition market.
- Key Trends - Highlights the major trends shaping the global parenteral nutrition market. This section also highlights likely future developments in the market.
- Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by type, by application, and by end-user in the market.
- Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies
- Conclusions And Recommendations
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered
1) By Composition: Amino Acids; Carbohydrates; Lipid Emulsion; Trace Elements; Vitamins And Minerals; Other Compositions2) By Consumer Type: Children And New-Born; Adults; Geriatrics
3) By End-User: Hospitals; Clinics; Homecare; And Other End-Users
Companies Mentioned: Baxter International, Inc.; Fresenius SE & Co. KGaA; Otsuka Pharmaceutical Factory, Inc.; B. Braun Melsungen AG; Sichuan Kelun Pharmaceutical Co., Ltd.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; parenteral nutrition indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Baxter International, Inc.
- Fresenius SE & Co. KGaA
- Otsuka Pharmaceutical Factory, Inc.
- B. Braun Melsungen AG
- Sichuan Kelun Pharmaceutical Co., Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 290 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 5823.4 Million |
| Forecasted Market Value ( USD | $ 10423.8 Million |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 5 |
